IP Library › Assignment 065474/0475
Patent Assignment
Reel/Frame 065474/0475

Assignment of Assignor's Interest

Recorded: 2023-11-06 Pages: 24
Assignor
WELLSTAT THERAPEUTICS CORPORATION
Executed: 2023-08-14
Assignee
PHARMA CINQ, LLC
1601 RESEARCH BOULEVARD, ROCKVILLE, MARYLAND, 20850
Covered Properties (30)
Compounds for the Treatment of Metabolic Disorders
Compounds for the Treatment of Metabolic Disorders
Compounds for the Treatment of Metabolic Disorders
Combination Treatment for Metabolic Disorders
Compounds for the Treatment of Metabolic Disorders
Patent: 7,101,910 →
Application: 10/167,839 →
Publication: US 2003/0149107
Compounds for the Treatment of Metabolic Disorders
Patent: 7,514,555 →
Application: 10/531,618 →
Publication: US 2006/0014784
Compounds for the Treatment of Metabolic Disorders
Patent: 7,615,575 →
Application: 10/531,630 →
Publication: US 2006/0247309
Compounds for the Treatment of Metabolic Disorders
Patent: 7,361,686 →
Application: 10/553,936 →
Publication: US 2007/0105955
Compounds for the Treatment of Metabolic Disorders
Patent: 7,442,796 →
Application: 10/554,586 →
Publication: US 2007/0173544
Compounds for the Treatment of Metabolic Disorders
Patent: 7,906,675 →
Application: 10/566,302 →
Publication: US 2007/0282003
Compounds for the Treatment of Metabolic Disorders
Patent: 7,041,659 →
Application: 10/684,735 →
Publication: US 2004/0092518
Method for the Treatment of Metabolic Disorders
Patent: 7,605,181 →
Application: 11/841,489 →
Publication: US 2008/0015254
Compounds for the Treatment of Metabolic Disorders
Patent: 8,022,249 →
Application: 11/909,120 →
Publication: US 2009/0234016
Compounds for the Treatment of Metabolic Disorders
Patent: 8,178,675 →
Application: 12/092,932 →
Publication: US 2009/0203793
Compounds for the Treatment of Metabolic Disorders
Patent: 7,915,429 →
Application: 12/160,857 →
Publication: US 2008/0319049
Compounds for the Treatment of Metabolic Disorders
Patent: 7,947,735 →
Application: 12/160,858 →
Publication: US 2008/0306150
Compounds for the Treatment of Metabolic Disorders
Patent: 8,044,243 →
Application: 12/279,247 →
Publication: US 2009/0176889
Combination Treatment of Metabolic Disorders
Patent: 8,338,480 →
Application: 12/294,530 →
Publication: US 2010/0292277
Compounds for the Treatment of Metabolic Disorders
Patent: 7,935,689 →
Application: 12/300,239 →
Publication: US 2009/0163576
Compounds for the Treatment of Metabolic Disorders
Patent: 7,973,052 →
Application: 12/392,675 →
Publication: US 2009/0156681
Method for the Treatment of Metabolic Disorders
Patent: 7,932,290 →
Application: 12/550,482 →
Publication: US 2010/0087541
Compounds for the Treatment of Metabolic Disorders
Patent: 8,481,595 →
Application: 12/812,514 →
Publication: US 2010/0286267
Compounds and Method for Reducing Uric Acid
Patent: 8,829,058 →
Application: 12/920,555 →
Publication: US 2011/0014176
Tetrazole Compounds for Reducing Uric Acid
Patent: 8,410,154 →
Application: 12/989,724 →
Publication: US 2011/0206653
Synthesis of 4-[3-(2,6-Dimethylbenzyloxy)Phenyl]-4-Oxobutanoic Acid
Patent: 8,664,433 →
Application: 12/990,851 →
Publication: US 2011/0201838
Synthesis of (Phenylalkyloxy)Phenyl-Oxobutanoic Acids
Patent: 8,703,991 →
Application: 13/127,120 →
Publication: US 2012/0004442
3-Substituted Compounds for Reducing Uric Acid
Patent: 8,546,448 →
Application: 13/501,338 →
Publication: US 2012/0201803
Tetrazole Compounds for Reducing Uric Acid
Patent: 8,889,724 →
Application: 13/783,680 →
Publication: US 2013/0336949
Compounds and Method for Reducing Uric Acid
Patent: 9,115,072 →
Application: 13/890,789 →
Publication: US 2013/0259850
Benzoic Acid Compounds for Reducing Uric Acid
Application: 15/293,365 →
Publication: US 2017/0042844
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 19, 2002
From: SHARMA, SHALINI; VON BORSTEL, REID W.; HODGE, KIRVIN L.
To: WELLSTAT THERAPEUTICS CORPORATION
Reel/Frame 013219/0513 →
Assignment of Assignor's Interest Mar 21, 2006
From: VENTURE MANAGEMENT ALLIANCE LLC
To: CDC INVESTMENTS, LLLP
Reel/Frame 017707/0189 →
Security Agreement Aug 16, 2013
From: WELLSTAT THERAPEUTICS CORPORATION
To: WHITE OAK GLOBAL ADVISORS, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 031029/0875 →
Security Agreement Sep 18, 2013
From: WELLSTAT THERAPEUTICS CORPORATION
To: PDL BIOPHARMA, INC.
Reel/Frame 031227/0227 →
Release of Security Interest Jan 21, 2021
From: WHITE OAK GLOBAL ADVISORS, LLC, AS ADMINISTRATIVE AGENT
To: WELLSTAT THERAPEUTICS CORPORATION
Reel/Frame 055056/0891 →